학술논문
Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium aviumComplex Pulmonary Disease
Document Type
Article
Author
Henkle, Emily; Quittner, Alexandra L.; Dieckmann, Nathan F.; Franklin, Heather; Brunton, Amanda E.; Daley, Charles L.; Winthrop, Kevin L.; Strnad, Luke; Varley, Cara; Lapidus, Jodi; Philley, Julie; McShane, Pamela; Devine, Megan; Griffith, David E.; Kasperbauer, Shannon H.; Huitt, Gwen; Eddy, Jared J.; Marras, Theodore K.; Brode, Sarah K.; Addrizzo-Harris, Dorreen; Springer, Amy; Flume, Patrick; Mingora, Christina; Alkabab, Yursa; Dorman, Susan; Naureckas, Ted; Aksamit, Timothy R.; Ruoss, Stephen; Hornick, Douglas B.; Mirsaeidi, Mehdi; Salathe, Matthias; Waller, Stephen; Schmid, Andreas; ElMaraachli, Wael; Cowell, Anne; Thakur, Neeta; Nahid, Payam; Zha, Shoshana; Ignatius, Elisa H.; Zenilman, Jonathan; Cohen, Keira; Belz, Daniel C.; Ali, Juzar; Lapinel, Nicole; Swenson, Colin; Kapolka, Rebecca; Horne, David; Salerno, Daniel; DiMango, Angela; Moretta, Dafne; Tan, Laren; Furukawa, Brian; Wysham, Nicholas; Noone, Peader; Daniels, Leigh Anne; Saddler, Chris; Misch, Elizabeth Ann; Hayes, Lisa; Epstein, Marcia; Kim, Angela; Myers, Janet N.
Source
Chest; 20230101, Issue: Preprints
Subject
Language
ISSN
00123692; 19313543
Abstract
Nontuberculous mycobacteria (NTM), predominately Mycobacterium aviumcomplex (MAC), cause chronic pulmonary disease. Improvements in symptoms and health-related quality of life (HRQoL) are important treatment outcomes, but no validated patient-reported outcome (PRO) measure exists.